— Know what they know.
Not Investment Advice

CRIS NASDAQ

Curis, Inc.
1W: -3.2% 1M: -41.8% 3M: -86.5% YTD: -95.9% 1Y: -97.6% 3Y: -99.5% 5Y: -100.0%
$0.80
-0.03 (-3.29%)
 
Weekly Expected Move ±6.7%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 25 · $1.6M mcap · 2M float · 14.67% daily turnover · Short 52% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$9M -13.4% ▼
5Y CAGR: -2.7%
Gross Profit
$9M -13.1% ▼
5Y CAGR: -1.8%
Operating Income
-$33M +26.1% ▲
Net Income
-$8M +82.5% ▲
EPS (Diluted)
$-0.58 +91.6% ▲
EBITDA
-$33M +23.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$11M$10M$10M$11M$9M
YoY Growth-1.7%-4.6%-1.4%+8.8%-13.4%
Cost of Revenue$533K$257K$212K$98K$45K
Gross Profit$10M$10M$10M$11M$9M
Gross Margin95.0%97.5%97.9%99.1%99.5%
R&D Expenses$35M$43M$39M$39M$28M
SG&A Expenses$17M$20M$19M$17M$14M
Operating Expenses$52M$63M$58M$55M$42M
Operating Income-$42M-$53M-$48M-$45M-$33M
Operating Margin-395.0%-521.7%-482.2%-408.3%-348.4%
Interest Expense$4M$5M$2M$615K$2M
Income Before Tax-$45M-$57M-$47M-$43M-$8M
Tax Expense$0$0$0$0$0
Net Income-$45M-$57M-$47M-$43M-$8M
Net Margin-426.7%-557.7%-473.0%-397.8%-80.3%
EPS (Diluted)$-9.92$-12.14$-8.96$-6.88$-0.58
EBITDA-$41M-$52M-$45M-$43M-$33M
Shares Outstanding5M5M5M6M132M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms